Login / Signup
SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients.
Wei-Lun Huang
Chi-Wen Luo
Huei-Shan Lin
Chao-Ming Hung
Fang-Ming Chen
Sin-Hua Moi
Mei-Ren Pan
Published in:
Cancer genomics & proteomics (2023)
Targeting SUV39H1 may provide a potential guiding indication of omitting RT to avoid over-treatment and chemosensitivity for TNBC.
Keyphrases
</>
lymph node
poor prognosis
early stage
neoadjuvant chemotherapy
radiation therapy
locally advanced
cancer therapy
squamous cell carcinoma
sentinel lymph node
drug delivery
risk assessment
replacement therapy
rectal cancer